<Version>
  <xmlSource>This XML content was developed by AHRQ's contractor ECRI Institute for the National Quality Measures Clearinghouse (NQMC).</xmlSource>
  <Section SecID="298" OrdBy="100" Name="General">
    <Field FieldID="11" OrdBy="105" ID="299" Name="Title" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_title&quot;&gt;Chronic kidney disease (CKD): percentage of calendar months during the 12 months reporting period in which patients aged 18 years and older with the diagnosis of advanced CKD (stage 4 or 5, not receiving RRT), receiving ESA therapy, have a hemoglobin less than 13 g/dL OR patients whose hemoglobin is greater than or equal to 13 g/dL have a documented plan of care.&lt;/div&gt;" />
    </Field>
    <Field FieldID="1" OrdBy="110" ID="300" Name="Source(s)" Type="citation">
      <FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Renal Physicians Association, Physician Consortium for Performance Improvement®. Chronic kidney disease physician performance measurement set. Chicago (IL): American Medical Association; 2007 Oct. 32 p.  [13 references]&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" />
    </Field>
  </Section>
  <Section SecID="301" OrdBy="200" Name="Measure Domain">
    <Field FieldID="25" OrdBy="205" ID="302" Name="Primary Measure Domain" Type="picklist-one">
      <FieldValue Value="Process&lt;div class=&quot;content_special_handling&quot;&gt;&lt;p&gt;The validity of measures depends on how they are built. By examining the key building blocks of a measure, you can assess its validity for your purpose. For more information, visit the &lt;a href=&quot;/selecting-and-using/validity.aspx&quot;&gt;Measure Validity&lt;/a&gt; page.&lt;p/&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="26" OrdBy="210" ID="303" Name="Secondary Measure Domain" Type="picklist-many">
      <FieldValue Value="Does not apply to this measure" />
    </Field>
  </Section>
  <Section SecID="304" OrdBy="300" Name="Brief Abstract">
    <Field FieldID="34" OrdBy="305" ID="305" Name="Description" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This measure is used to assess the percentage of calendar months during the 12 months reporting period in which patients aged 18 years and older with the diagnosis of advanced chronic kidney disease (CKD) (stage 4 or 5, not receiving renal replacement therapy [RRT]), receiving erythropoiesis-stimulating agent (ESA) therapy, have a hemoglobin less than 13 g/dL OR patients whose hemoglobin is greater than or equal to 13 g/dL have a documented plan of care.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="21" OrdBy="310" ID="306" Name="Rationale" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The clinical recommendation regarding hemoglobin (Hb) levels for chronic kidney disease (CKD) patients receiving erythropoiesis-stimulating agent (ESA) therapy is that Hb level should generally be in the range of 11.0 to 12.0 g/dL. Additionally, these patients should also have their Hb level checked at least monthly. Given that Hb levels vary for each patient due to numerous factors, it is necessary to monitor Hb level closely in order to make the individualized treatment decisions required in maintaining Hb level in the target range. There is no evidence of benefit from ESA therapy when Hb levels are maintained at greater than 13.0 g/dL. Maintaining Hb at higher levels may result in potential harm to the patient, as well as incur unjustified cost. Evidence linking increased risks for patients with CKD and higher Hb levels were for target Hb levels greater than 13.0 g/dL. The intention of this measure is not to suggest that the goal of ESA treatment is to reach an achieved Hb of 13.0 g/dL. Rather, as a patient safety measure, it is to realize that patients who reach Hb levels higher than 13.0 g/dL are at increased risk for adverse events, and that these elevated Hb levels need to be addressed by adjusting ESA dosage.*&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;*The following clinical recommendation statements are quoted &lt;u&gt;verbatim&lt;/u&gt; from the referenced clinical guidelines and represent the evidence base for the measure:&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;The frequency of HB monitoring in patients treated with ESAs should be at least monthly. (National Kidney Foundation [NKF], 2006)&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;The HB target is the intended aim of ESA therapy for the individual patient with CKD. In clinical practice, achieved Hb results vary considerably from Hb target.&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;ul class=&quot;contentListFont&quot;&gt;&#xD;&#xA;&lt;li&gt;Selection of the Hb target and selection of the Hb level at which ESA therapy is initiated in the individual patient should include consideration of potential benefits (including improvement in the quality of life and avoidance of transfusion) and potential harms (including the risk of life-threatening adverse events). (NKF, 2007)&lt;/li&gt;&#xD;&#xA;&lt;li&gt;In dialysis and nondialysis patients with CKD receiving ESA therapy, the selected Hb target should generally be in the range of 11.0 to 12.0 g/dL. (NKF, 2007)&lt;/li&gt;&#xD;&#xA;&lt;li&gt;In dialysis and nondialysis patients with CKD receiving ESA therapy, the Hb target should not be greater than 13.0 g/dL. (NKF, 2007)&lt;/li&gt;&#xD;&#xA;&lt;li&gt;The initial ESA dose and the ESA dose adjustments should be determined by the patient's Hb level, the target Hb level, the observed rate of increase in Hb level, and clinical circumstances. (NKF, 2006)&lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;ESA doses should be decreased, but not necessarily held, when a downward adjustment of Hb level is needed. (NKF, 2006)&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="22" OrdBy="315" ID="307" Name="Primary Clinical Component" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Chronic kidney disease (CKD); erythropoiesis-stimulating agent (ESA) therapy; hemoglobin&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="23" OrdBy="320" ID="308" Name="Denominator Description" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Calendar months for all patients aged 18 years and older with the diagnosis of advanced chronic kidney disease (CKD) (stage 4 or 5, not receiving renal replacement therapy [RRT]), receiving erythropoiesis-stimulating agent (ESA) therapy&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="24" OrdBy="325" ID="309" Name="Numerator Description" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Number of calendar months during which patients' hemoglobin level is less than 13 g/dL OR patients whose hemoglobin level is greater than or equal to 13 g/dL and have a documented plan of care (see the related &quot;Numerator Inclusions/Exclusions&quot; field)&lt;/p&gt;&lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="310" OrdBy="400" Name="Evidence Supporting the Measure">
    <Field FieldID="27" OrdBy="405" ID="311" Name="Evidence Supporting the Criterion of Quality" Type="picklist-choice">
      <FieldValue Value="A clinical practice guideline or other peer-reviewed synthesis of the clinical evidence" />
      <FieldValue Value="One or more research studies published in a National Library of Medicine (NLM) indexed, peer-reviewed journal" />
    </Field>
  </Section>
  <Section SecID="315" OrdBy="500" Name="Evidence Supporting Need for the Measure">
    <Field FieldID="28" OrdBy="505" ID="316" Name="Need for the Measure" Type="picklist-choice">
      <FieldValue Value="Unspecified" />
    </Field>
  </Section>
  <Section SecID="318" OrdBy="600" Name="State of Use of the Measure">
    <Field FieldID="29" OrdBy="605" ID="319" Name="State of Use" Type="picklist-one">
      <FieldValue Value="Current routine use" />
    </Field>
    <Field FieldID="30" OrdBy="610" ID="320" Name="Current Use" Type="picklist-choice">
      <FieldValue Value="Internal quality improvement" />
      <FieldValue Value="National reporting" />
    </Field>
  </Section>
  <Section SecID="321" OrdBy="700" Name="Application of Measure in its Current Use">
    <Field FieldID="31" OrdBy="705" ID="322" Name="Care Setting" Type="picklist-choice">
      <FieldValue Value="Ambulatory Care" />
      <FieldValue Value="Physician Group Practices/Clinics" />
    </Field>
    <Field FieldID="32" OrdBy="710" ID="323" Name="Professionals Responsible for Health Care" Type="picklist-choice">
      <FieldValue Value="Physicians" />
    </Field>
    <Field FieldID="33" OrdBy="715" ID="324" Name="Lowest Level of Health Care Delivery Addressed" Type="picklist-one">
      <FieldValue Value="Individual Clinicians" />
    </Field>
    <Field FieldID="41" OrdBy="720" ID="325" Name="Target Population Age" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Age greater than or equal to 18 years&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="42" OrdBy="725" ID="326" Name="Target Population Gender" Type="picklist-one">
      <FieldValue Value="Either male or female" />
    </Field>
    <Field FieldID="44" OrdBy="730" ID="327" Name="Stratification by Vulnerable Populations" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Unspecified&lt;/p&gt;&lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="328" OrdBy="800" Name="Characteristics of the Primary Clinical Component">
    <Field FieldID="45" OrdBy="805" ID="329" Name="Incidence/Prevalence" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Unspecified&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="46" OrdBy="815" ID="331" Name="Association with Vulnerable Populations" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Unspecified&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="47" OrdBy="825" ID="333" Name="Burden of Illness" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Unspecified&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="48" OrdBy="835" ID="335" Name="Utilization" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Unspecified&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="49" OrdBy="845" ID="337" Name="Costs" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Unspecified&lt;/p&gt;&lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="339" OrdBy="900" Name="Institute of Medicine (IOM) Healthcare Quality Report Categories">
    <Field FieldID="163" OrdBy="905" ID="340" Name="IOM Care Need" Type="picklist-choice">
      <FieldValue Value="Living with Illness" />
    </Field>
    <Field FieldID="164" OrdBy="910" ID="341" Name="IOM Domain" Type="picklist-choice">
      <FieldValue Value="Effectiveness" />
    </Field>
  </Section>
  <Section SecID="342" OrdBy="1000" Name="Data Collection for the Measure">
    <Field FieldID="52" OrdBy="1005" ID="343" Name="Case Finding" Type="picklist-one">
      <FieldValue Value="Users of care only" />
    </Field>
    <Field FieldID="53" OrdBy="1010" ID="344" Name="Description of Case Finding" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Calendar months for all patients aged 18 years and older with the diagnosis of advanced chronic kidney disease (CKD) (stage 4 or 5, not receiving renal replacement therapy [RRT]), receiving erythropoiesis-stimulating agent (ESA) therapy&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="54" OrdBy="1015" ID="345" Name="Denominator Sampling Frame" Type="picklist-one">
      <FieldValue Value="Patients associated with provider" />
    </Field>
    <Field FieldID="55" OrdBy="1020" ID="346" Name="Denominator Inclusions/Exclusions" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Inclusions&lt;/strong&gt;&lt;br /&gt;&#xD;&#xA;Calendar months for all patients aged 18 years and older with the diagnosis of advanced chronic kidney disease (CKD) (stage 4 or 5, not receiving renal replacement therapy [RRT]), receiving erythropoiesis-stimulating agent (ESA) therapy&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Exclusions&lt;/strong&gt;&lt;br /&gt; &#xD;&#xA;None&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="56" OrdBy="1025" ID="347" Name="Relationship of Denominator to Numerator" Type="picklist-one">
      <FieldValue Value="All cases in the denominator are equally eligible to appear in the numerator" />
    </Field>
    <Field FieldID="57" OrdBy="1030" ID="348" Name="Denominator (Index) Event" Type="picklist-choice">
      <FieldValue Value="Clinical Condition" />
      <FieldValue Value="Encounter" />
      <FieldValue Value="Therapeutic Intervention" />
    </Field>
    <Field FieldID="58" OrdBy="1035" ID="349" Name="Denominator Time Window" Type="picklist-one">
      <FieldValue Value="Time window brackets index event" />
    </Field>
    <Field FieldID="59" OrdBy="1040" ID="350" Name="Numerator Inclusions/Exclusions" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Inclusions&lt;/strong&gt;&lt;br /&gt;&#xD;&#xA;Number of calendar months during which patients' hemoglobin level is less than 13 g/dL OR patients whose hemoglobin level is greater than or equal to 13 g/dL and have a documented plan of care*&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;*A documented plan of care should include reducing the erythropoiesis-stimulating agent (ESA) dose and repeating hemoglobin at a specified future date.&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Exclusions&lt;/strong&gt;&lt;br /&gt; &#xD;&#xA;None&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="60" OrdBy="1045" ID="351" Name="Measure Results Under Control of Health Care Professionals, Organizations and/or Policymakers" Type="picklist-one">
      <FieldValue Value="The measure results are somewhat or substantially under the control of the health care professionals, organizations and/or policymakers to whom the measure applies." />
    </Field>
    <Field FieldID="61" OrdBy="1050" ID="352" Name="Numerator Time Window" Type="picklist-one">
      <FieldValue Value="Fixed time period" />
    </Field>
    <Field FieldID="62" OrdBy="1055" ID="353" Name="Data Source" Type="picklist-choice">
      <FieldValue Value="Administrative data " />
      <FieldValue Value="Medical record" />
    </Field>
    <Field FieldID="63" OrdBy="1060" ID="354" Name="Level of Determination of Quality" Type="picklist-one">
      <FieldValue Value="Individual Case" />
    </Field>
    <Field FieldID="66" OrdBy="1075" ID="357" Name="Pre-existing Instrument Used" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Unspecified&lt;/p&gt;&lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="358" OrdBy="1100" Name="Computation of the Measure">
    <Field FieldID="67" OrdBy="1105" ID="359" Name="Scoring" Type="picklist-one">
      <FieldValue Value="Rate" />
    </Field>
    <Field FieldID="68" OrdBy="1110" ID="360" Name="Interpretation of Score" Type="picklist-one">
      <FieldValue Value="Better quality is associated with a higher score" />
    </Field>
    <Field FieldID="90" OrdBy="1115" ID="361" Name="Allowance for Patient Factors" Type="picklist-choice">
      <FieldValue Value="Unspecified" />
    </Field>
    <Field FieldID="70" OrdBy="1125" ID="363" Name="Standard of Comparison" Type="picklist-choice">
      <FieldValue Value="Internal time comparison" />
    </Field>
  </Section>
  <Section SecID="366" OrdBy="1200" Name="Evaluation of Measure Properties">
    <Field FieldID="72" OrdBy="1205" ID="367" Name="Extent of Measure Testing" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Unspecified&lt;/p&gt;&lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="369" OrdBy="1300" Name="Identifying Information">
    <Field FieldID="73" OrdBy="1301" ID="473" Name="Original Title" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Measure #4: plan of care -- elevated hemoglobin for patients receiving erythropoiesis-stimulating agents (ESA).&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="74" OrdBy="1303" ID="474" Name="Measure Collection Name" Type="text">
      <FieldValue Value="The Physician Consortium for Performance Improvement&amp;#174; Measurement Sets" />
    </Field>
    <Field FieldID="75" OrdBy="1305" ID="475" Name="Measure Set Name" Type="text">
      <FieldValue Value="Chronic Kidney Disease Physician Performance Measurement Set" />
    </Field>
    <Field FieldID="16" OrdBy="1310" ID="371" Name="Submitter" Type="orglist">
      <FieldValue Value="American Medical Association on behalf of the Renal Physicians Association and Physician Consortium for Performance Improvement® - Medical Specialty Society" />
    </Field>
    <Field FieldID="17" OrdBy="1315" ID="372" Name="Developer" Type="orglist-p">
      <FieldValue Value="Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration" />
      <FieldValue Value="Renal Physicians Association - Medical Specialty Society" />
    </Field>
    <Field FieldID="79" OrdBy="1320" ID="373" Name="Funding Source(s)" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Unspecified&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="80" OrdBy="1325" ID="374" Name="Composition of the Group that Developed the Measure" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;William Haley, MD (&lt;em&gt;Co-Chair&lt;/em&gt;); Bonnie McCafferty, MD, MSPH (&lt;em&gt;Co-Chair&lt;/em&gt;); &#xD;&#xA;Todd Davis, MD; Barbara Fivush, MD; Richard S. Goldman, MD; John Hartman, MD; Richard Hellman, MD, FACP, FACE; Edward Jones, MD; Craig B. Langman, MD; Cathi Martin, RD; Charles McAllister, MD, MBA, FCAP; Paul Rockswold, MD, MPH; Sam J.W. Romeo, MD, MBA; Anton C. Schoolwerth, MD, FAHA; Lesley Stevens, MD; Joseph Vassalotti, MD; Candace Walworth, MD; Don Wesson, MD; David Witte, MD, PhD, FCAP; Jerry Yee, MD&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;Robert Blaser, Renal Physicians Association; Dale Singer, Renal Physicians Association&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;Phil Renner, MBA, National Committee for Quality Assurance&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;Susan Nedza, MD, MBA, FACEP, Centers for Medicare &amp; Medicaid Services; Desurai Wilson, Centers for Medicare &amp; Medicaid Services&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;Chris Izui, Health Plan Representative (BCBS)&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;Elvira Ryan, RN, The Joint Commission; Ann Watts, RN, The Joint Commission&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;Kendra Hanley, MS, CHE, American Medical Association; Erin O. Kaleba, MPH, American Medical Association; Karen S. Kmetik, PhD, American Medical Association&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;Rebecca A. Kresowik, Facilitator; Timothy F. Kresowik, MD, Facilitator&lt;/p&gt;&#xD;&#xA;&lt;/div&gt;" />
    </Field>
    <Field FieldID="81" OrdBy="1330" ID="375" Name="Financial Disclosures/Other Potential Conflicts of Interest" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Conflicts, if any, are disclosed in accordance with the Physician Consortium for Performance Improvement&amp;#174; conflict of interest policy.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="83" OrdBy="1340" ID="377" Name="Included in" Type="picklist-choice">
      <FieldValue Value="Ambulatory Care Quality Alliance" />
      <FieldValue Value="Physician Quality Reporting Initiative" />
    </Field>
    <Field FieldID="19" OrdBy="1345" ID="378" Name="Adaptation" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Measure was not adapted from another source.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="85" OrdBy="1355" ID="380" Name="Release Date" Type="date">
      <FieldValue Value="2007 Oct" />
    </Field>
    <Field FieldID="20" OrdBy="1365" ID="382" Name="Measure Status" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the measure.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The Physician Consortium for Performance Improvement reaffirmed the currency of this measure in November 2010.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="1" OrdBy="1366" ID="300" Name="Source(s)" Type="citation">
      <FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Renal Physicians Association, Physician Consortium for Performance Improvement®. Chronic kidney disease physician performance measurement set. Chicago (IL): American Medical Association; 2007 Oct. 32 p.  [13 references]&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" />
    </Field>
    <Field FieldID="14" OrdBy="1370" ID="383" Name="Measure Availability" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The individual measure, &quot;Measure #4: Plan of Care -- Elevated Hemoglobin for Patients Receiving Erythropoiesis-Stimulating Agents (ESA),&quot; is published in the &quot;Chronic Kidney Disease Physician Performance Measurement Set.&quot; This document and technical specifications are available in Portable Document Format (PDF) from the American Medical Association (AMA)-convened Physician Consortium for Performance Improvement&amp;#174; Web site: &lt;a href=&quot;http://www.physicianconsortium.org&quot; target=&quot;_blank&quot; title=&quot;AMA Web site&quot;&gt;www.physicianconsortium.org&lt;/a&gt;.&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;For further information, please contact AMA staff by e-mail at &lt;a href=&quot;mailto:cqi@ama-assn.org&quot;&gt;cqi@ama-assn.org&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="87" OrdBy="1380" ID="385" Name="NQMC Status" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NQMC summary was completed by ECRI Institute on March 27, 2008. The information was verified by the measure developer on June 11, 2008. The information was reaffirmed by the measure developer on November 17, 2010.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="88" OrdBy="1385" ID="386" Name="Copyright Statement" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&amp;#169; 2007 American Medical Association. All Rights Reserved.&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;CPT&amp;#174; Copyright 2006 American Medical Association&lt;/p&gt;&lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="99999" OrdBy="99999" Name="Disclaimer">
    <Field FieldID="99999" OrdBy="99999" ID="99999" Name="NQMC Disclaimer" Type="text">
      <FieldValue Value="&lt;p&gt;The National Quality Measures Clearinghouse™ (NQMC) does not develop, produce, approve, or endorse the measures represented on this site.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;All measures summarized by NQMC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public and private organizations, other government agencies, health care organizations or plans, individuals, and similar entities.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Measures represented on the NQMC Web site are submitted by measure developers, and are screened solely to determine that they meet the &lt;a href=&quot;/help-and-about/summaries/inclusion-criteria&quot;&gt;NQMC Inclusion Criteria&lt;/a&gt;.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;NQMC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or its reliability and/or validity of the quality measures and related materials represented on this site. Moreover, the views and opinions of developers or authors of measures represented on this site do not necessarily state or reflect those of NQMC, AHRQ, or its contractor, ECRI Institute, and inclusion or hosting of measures in NQMC may not be used for advertising or commercial endorsement purposes.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Readers with questions regarding measure content are directed to contact the measure developer.&lt;/p&gt;" />
    </Field>
  </Section>
</Version>